What omega-3 index should an APOE4 carrier aim for?

The omega-3 index bands

The optimal band includes both ends: 10.0 and 12.0 are optimal, and 12.1 is above target. "Under 10" excludes 10, so 9.9 is Monitor. "Under 4" excludes 4, so 4.0 is Monitor.

Confidence: moderate for the heart line at 8%; low for the brain. The 10 to 12% aim is a Phoenix choice with no study behind the exact numbers.

What is the omega-3 index?

The omega-3 index is the share of EPA and DHA, the two marine omega-3 fats, in your red blood cell membranes. It reflects your intake over the past few months rather than your last meal. Red cell membranes take about 5 months to settle at a new level after you change your intake (Flock, 2013).

Most Americans who do not take omega-3 supplements sit at about 4 to 5% (Flock, 2013).

Ask for the "omega-3 index" by name. A plasma omega-3 result is a different measurement, and you cannot read it against these bands.

Why does the omega-3 index matter for your brain?

Higher omega-3 status goes with less Alzheimer's, a larger brain and sharper thinking, and it decides whether B vitamins work.

• Alzheimer's. In 1,490 people aged 65 or older in the Framingham Offspring Study, followed for 7.2 years, those in the highest fifth of red-cell DHA had 49% less Alzheimer's than those in the lowest fifth (hazard ratio 0.51). The authors estimated 4.7 extra years free of Alzheimer's from moving bottom to top (Sala-Vila, 2022).
• Brain size and thinking. In 1,575 Framingham participants without dementia, those in the lowest quarter of red-cell DHA had smaller brains and more white-matter damage. A low DHA and a low omega-3 index went with lower scores in visual memory, executive function and abstract thinking (Tan, 2012).
• The B-vitamin link. In the VITACOG trial, B vitamins slowed brain shrinkage by 40% in people with high blood omega-3, and had no effect in people with low omega-3 (Jernerén, 2015). See the homocysteine page.
• The heart, where the 8% line comes from. An omega-3 index of 8% or more went with the greatest protection from death from heart disease (Harris, 2004). Across 17 cohorts with 42,466 people followed for a median of 16 years, people in the highest fifth of blood EPA, DPA and DHA had a 15 to 18% lower risk of death from any cause than those in the lowest fifth (Harris, 2021).

What does APOE4 change?

Carriers appear to get less omega-3 into the brain from the same dose, and the DHA link to Alzheimer's looked stronger in carriers.

• Delivery to the brain. In a randomized trial, 2,152 mg of DHA a day for 6 months raised DHA in the spinal fluid by 28% and EPA by 43% against placebo. The rise in spinal-fluid EPA was three times greater in non-carriers than in carriers. The authors concluded that trials using 1 g a day or less may have had weaker brain effects, particularly in carriers (Arellanes, 2020). The trial was small: 33 people.
• The Alzheimer's link. In the Framingham Offspring Study, each step up in red-cell DHA went with a lower Alzheimer's risk in carriers (hazard ratio 0.71 per standard deviation, borderline significant) and a weaker, non-significant link in non-carriers (0.85) (Sala-Vila, 2022).
• The trial that will test it. PreventE4 randomized 365 cognitively healthy people aged 55 to 80 to 2 g of DHA a day or placebo for 2 years, to test brain delivery and brain imaging in carriers (Yassine, 2023). Its main results were not in PubMed when this page was reviewed.

What did Phoenix choose, and why above 8%?

I chose 10 to 12% as Phoenix's target for carriers. The 8% line comes from the heart research that created the index (Harris, 2004). Carriers appear to move less omega-3 into the brain from the same intake (Arellanes, 2020), and the DHA link to Alzheimer's looked stronger in carriers (Sala-Vila, 2022). Given everything else I'm managing as a 4/4 carrier, I want the headroom.

The honest part, said once: no study has tested 10 to 12% in carriers. It is a Phoenix choice, the same way under 60 for ApoB is a Phoenix choice. Above 12%, Phoenix sees no reason to push higher.

What moves the omega-3 index?

Here are the levers, ranked by how much they move the index. These are facts about what each one does, not a dose for you.

1. EPA and DHA dose: the biggest lever by far. In a randomized dose trial, daily doses of 0 to 1,800 mg of EPA plus DHA for about 5 months showed that dose alone explained 68% of the change. At 1,800 mg a day, the index rose on average from 4.3% to 9.5% (Flock, 2013). Pooling 14 trials with 1,422 people, an average of about 2 g a day for about 14 weeks raised the index from 4.9% to 8.1%; 850 mg a day of an ethyl-ester supplement was predicted to take 4.9% to about 6.5% (Walker, 2019).
2. Your starting point and your weight. Dose, starting index and supplement form together explained 62% of the response (Walker, 2019). Body weight matters too: dose per kilogram of body weight predicted the response slightly better than dose alone (Flock, 2013).
3. The form of the supplement: about 1 point. Gram for gram, triglyceride-form supplements raised the index about 1 percentage point more than ethyl-ester products (Walker, 2019).
4. Fish counts, plant omega-3 does not. The index measures EPA and DHA only, so oily fish and fish or algae oils move it. The plant omega-3 ALA, from flax, chia and walnuts, is a different fat, and in 17 cohorts it showed no link with lower death rates (Harris, 2021).

The trade-off: in heart trials, marine omega-3 supplements raised the rate of atrial fibrillation, an irregular heart rhythm, by about 25% overall and by about 49% in trials using more than 1 g a day (Gencer, 2021). On average, it takes more than 1 g a day of EPA plus DHA to get from 4 to 5% into the 10 to 12% band (Flock, 2013; Walker, 2019), so this is worth a conversation with your doctor if your heart rhythm is a concern.

What Phoenix members use: among Phoenix members who log their supplements, 184 have logged an omega-3 (fish oil, krill oil or a DHA product), and 181 log one as taking now (2 October 2026).

How often should you retest?

No guideline sets a retest interval for the omega-3 index. Red cell membranes take about 5 months to reach a new steady level after a change in intake (Flock, 2013), so testing sooner shows a change that is still moving.

Phoenix practice: retest 4 to 5 months after you start or change an omega-3 supplement. Once you are in 10 to 12%, keep the omega-3 index in your regular panel.

At Phoenix, fewer than 10 members have retested their omega-3 index. If you take an omega-3, measure it.

What Phoenix members' results show

Start with the whole group. 35 Phoenix members who uploaded their results have an omega-3 index on file (2 October 2026), 19 of them with 4/4. Their median latest index is 9.2%.

• 28 of the 35 (80%) are at 8% or higher, the heart-research line.
• 15 of the 35 (43%) are at 10% or higher, the Phoenix aim.
• The biggest group, 13 members, sits at 8 to under 10%: past the research line, short of the Phoenix aim.

Fewer than 10 members have tested their omega-3 index twice, so Phoenix has no member data yet on what moves it. That is the gap worth closing: 184 members log an omega-3 supplement, and almost none measure whether it reaches the target. Every figure here is an anonymous aggregate.

When should you talk to your doctor?

Talk to your doctor about your intake if your omega-3 index is under 4%. That is the level research links to the least heart protection (Harris, 2004). It is not an emergency.

Also talk to your doctor before taking more than 1 g a day of EPA plus DHA if you have atrial fibrillation or another heart rhythm problem: in heart trials, higher doses went with more atrial fibrillation (Gencer, 2021).

If you take a prescribed omega-3 medicine, do not change it because of this page.